Literature DB >> 20859117

The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond.

Alexander Marx1, Peter Hohenberger, Hans Hoffmann, Joachim Pfannschmidt, Philipp Schnabel, Hans-Stefan Hofmann, Karsten Wiebe, Berthold Schalke, Wilfred Nix, Ralf Gold, Nick Willcox, Pärt Peterson, Philipp Ströbel.   

Abstract

Thymomas are tumors of thymic epithelial cells. They associate more often than any other human tumors with various autoimmune diseases; myasthenia gravis is the commonest, occurring in 10-50% of thymoma patients, depending on the World Health Organization-defined histologic subtype. Most thymomas generate many polyclonal maturing T lymphocytes but in disorganized microenvironments Failure to induce self-tolerance may be a key factor leading to the export of potentially autoreactive CD4 progeny, thus predisposing to autoimmune diseases. Normally, the master Autoimmune Regulator promotes expression of peripheral tissue-restricted antigens such as insulin by medullary thymic epithelial cells and induction of tolerance to them. The failure of approximately 95% of thymomas to express autoimmune regulator is another feature potentially contributing to autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859117     DOI: 10.1097/JTO.0b013e3181f1f63f

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  22 in total

1.  Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis.

Authors:  Jacqueline Mays; Cherié L Butts
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

Review 2.  Thymic tolerance as a key brake on autoimmunity.

Authors:  Mickie Cheng; Mark S Anderson
Journal:  Nat Immunol       Date:  2018-06-20       Impact factor: 25.606

Review 3.  Aire and T cell development.

Authors:  Mark S Anderson; Maureen A Su
Journal:  Curr Opin Immunol       Date:  2010-12-14       Impact factor: 7.486

4.  Immune-mediated diseases and immunodeficiencies associated with thymic epithelial neoplasms.

Authors:  Muhammad Rizwan Khawaja; Robert P Nelson; Nicholas Miller; Sunil S Badve; Elizabeth Loehrer; Magdalena Czader; Susan M Perkins; Kenneth Kesler; Patrick J Loehrer
Journal:  J Clin Immunol       Date:  2012-01-08       Impact factor: 8.317

5.  Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells.

Authors:  Francesca Bianchi; Michele Sommariva; Loris De Cecco; Tiziana Triulzi; Sandra Romero-Cordoba; Elda Tagliabue; Lucia Sfondrini; Andrea Balsari
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

6.  Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases.

Authors:  Nadine Dragin; Jacky Bismuth; Géraldine Cizeron-Clairac; Maria Grazia Biferi; Claire Berthault; Alain Serraf; Rémi Nottin; David Klatzmann; Ana Cumano; Martine Barkats; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

7.  CD4 and CD8 double-negative immunophenotype of thymoma-associated lymphocytes in a dog.

Authors:  Yvonne M Wikander; Kaori Knights; Calli Coffee; William Vernau; David S Biller; Mary Lynn Higginbotham; Nora L Springer
Journal:  J Vet Diagn Invest       Date:  2020-08-19       Impact factor: 1.279

Review 8.  [Thymus cancers: A clinical observation].

Authors:  H Grosch; H Hoffmann; C-A Weis; M Thomas
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

9.  Emerging treatment options for patients with recurrent advanced thymic epithelial tumors.

Authors:  Tracey L Evans
Journal:  Onco Targets Ther       Date:  2012-09-07       Impact factor: 4.147

Review 10.  Expression of the autoimmune regulator gene and its relevance to the mechanisms of central and peripheral tolerance.

Authors:  Roberto Perniola
Journal:  Clin Dev Immunol       Date:  2012-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.